Equifax (EFX) Competitors $236.89 +4.54 (+1.96%) Closing price 10/3/2025 03:59 PM EasternExtended Trading$236.68 -0.21 (-0.09%) As of 08:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EFX vs. CCRN, CRAI, APTV, FI, IQV, IT, OMC, RHI, TRU, and WMShould you be buying Equifax stock or one of its competitors? The main competitors of Equifax include Cross Country Healthcare (CCRN), Charles River Associates (CRAI), Aptiv (APTV), Fiserv (FI), IQVIA (IQV), Gartner (IT), Omnicom Group (OMC), Robert Half (RHI), TransUnion (TRU), and Waste Management (WM). Equifax vs. Its Competitors Cross Country Healthcare Charles River Associates Aptiv Fiserv IQVIA Gartner Omnicom Group Robert Half TransUnion Waste Management Cross Country Healthcare (NASDAQ:CCRN) and Equifax (NYSE:EFX) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk. Is CCRN or EFX more profitable? Equifax has a net margin of 10.95% compared to Cross Country Healthcare's net margin of -0.70%. Equifax's return on equity of 18.89% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Cross Country Healthcare-0.70% 1.72% 1.24% Equifax 10.95%18.89%7.84% Which has more volatility and risk, CCRN or EFX? Cross Country Healthcare has a beta of 0.39, suggesting that its stock price is 61% less volatile than the S&P 500. Comparatively, Equifax has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500. Which has stronger earnings and valuation, CCRN or EFX? Equifax has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCross Country Healthcare$1.19B0.36-$14.56M-$0.26-50.65Equifax$5.68B5.16$604.10M$5.1146.36 Does the media refer more to CCRN or EFX? In the previous week, Equifax had 45 more articles in the media than Cross Country Healthcare. MarketBeat recorded 46 mentions for Equifax and 1 mentions for Cross Country Healthcare. Equifax's average media sentiment score of 0.84 beat Cross Country Healthcare's score of -0.50 indicating that Equifax is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Equifax 11 Very Positive mention(s) 6 Positive mention(s) 9 Neutral mention(s) 4 Negative mention(s) 2 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in CCRN or EFX? 96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 96.2% of Equifax shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by company insiders. Comparatively, 1.4% of Equifax shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts recommend CCRN or EFX? Cross Country Healthcare presently has a consensus target price of $17.93, indicating a potential upside of 36.14%. Equifax has a consensus target price of $282.47, indicating a potential upside of 19.24%. Given Cross Country Healthcare's higher possible upside, equities research analysts clearly believe Cross Country Healthcare is more favorable than Equifax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cross Country Healthcare 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86Equifax 0 Sell rating(s) 8 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.67 SummaryEquifax beats Cross Country Healthcare on 15 of the 17 factors compared between the two stocks. Get Equifax News Delivered to You Automatically Sign up to receive the latest news and ratings for EFX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EFX vs. The Competition Export to ExcelMetricEquifaxConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$29.33B$6.60B$33.24B$21.78BDividend Yield0.85%1.71%2.84%3.55%P/E Ratio46.3623.2626.7629.82Price / Sales5.162.78744.8466.04Price / Cash18.4416.5728.6518.31Price / Book6.105.508.324.65Net Income$604.10M$272.15M$197.27M$1.00B7 Day Performance-7.42%0.44%1.50%1.20%1 Month Performance-5.17%4.01%12.55%3.32%1 Year Performance-16.47%-8.12%56.94%13.11% Equifax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EFXEquifax4.9159 of 5 stars$236.89+2.0%$282.47+19.2%-16.5%$29.33B$5.68B46.3614,700Trending NewsAnalyst ForecastAnalyst RevisionCCRNCross Country Healthcare3.3549 of 5 stars$13.76-3.3%$17.93+30.3%+7.6%$450.78M$1.34B-52.928,205CRAICharles River Associates4.0868 of 5 stars$205.22+0.0%$235.00+14.5%+11.1%$1.35B$687.41M24.85940APTVAptiv4.2699 of 5 stars$85.84-0.4%$85.73-0.1%+25.1%$18.69B$19.71B19.64141,000Positive NewsFIFiserv4.9799 of 5 stars$130.17+0.5%$205.96+58.2%-31.2%$70.76B$20.46B21.7338,000IQVIQVIA4.8132 of 5 stars$181.00+0.8%$229.64+26.9%-10.0%$30.77B$15.41B26.1988,000Positive NewsITGartner4.8664 of 5 stars$261.19-1.1%$357.44+36.9%-49.8%$19.78B$6.30B16.0721,044OMCOmnicom Group4.778 of 5 stars$79.10+2.7%$96.29+21.7%-23.6%$15.32B$15.69B11.3574,900Positive NewsRHIRobert Half4.8542 of 5 stars$34.23+0.6%$45.83+33.9%-48.2%$3.48B$5.80B19.5614,700TRUTransUnion4.8434 of 5 stars$85.20+0.0%$112.64+32.2%-26.1%$16.60B$4.18B42.6013,400Trending NewsAnalyst RevisionWMWaste Management4.9468 of 5 stars$219.24+0.2%$255.17+16.4%+5.6%$88.31B$22.06B32.5361,700 Related Companies and Tools Related Companies Cross Country Healthcare Alternatives Charles River Associates Alternatives Aptiv Alternatives Fiserv Alternatives IQVIA Alternatives Gartner Alternatives Omnicom Group Alternatives Robert Half Alternatives TransUnion Alternatives Waste Management Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EFX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equifax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equifax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
